Global Vascular Closure Device? Market Growth 2025-2031

The global Vascular Closure Device​ market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Vascular closure devices (VCDs) are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. vascular closure device is usually a piece of collagen (a fibrous protein found in skin, bone and connective tissue), metallic clip or suture (stitch) designed to provide immediate sealing of the small puncture made in an artery after an angiogram. Angiography is the imaging of blood vessels that appear on live X-ray images or pictures. This helps show abnormalities or to guide the treatment of disease. Arterial access is commonly carried out through the femoral artery, which is a large artery running past the region of the groin. Access through this artery involves a specialist doctor puncturing the artery with a small needle through the skin and inserting a plastic sheath or tube into the artery through the puncture site. Once the angiographic procedure is complete, the plastic sheath providing access to the femoral artery will need to be removed. This will leave behind a small hole in the artery, corresponding to the size of the plastic sheath. The hole will continue to bleed, unless treated. Stopping the flow of blood from this hole is normally achieved by manual compression with the doctor’s or nurse’s fingers placed directly over the site of the hole in the artery. Manual compression is usually very effective, but can take 10–15 minutes or longer, depending on the size of the plastic sheath placed in the artery. Manual compression requires patients to lie flat in bed with the hips in a straight position for at least 4 hours after the plastic sheath is removed. Vascular closure devices provide an alternative to manual compression. These devices provide immediate sealing of the femoral artery access site, so there is no need for prolonged compression.

United States market for Vascular Closure Device​ is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Vascular Closure Device​ is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Vascular Closure Device​ is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Vascular Closure Device​ players cover Teleflex Incorporated, Abbott Laboratories, Boston Scientific Corporation, BD, Medtronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Vascular Closure Device​ Industry Forecast” looks at past sales and reviews total world Vascular Closure Device​ sales in 2024, providing a comprehensive analysis by region and market sector of projected Vascular Closure Device​ sales for 2025 through 2031. With Vascular Closure Device​ sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Closure Device​ industry.

This Insight Report provides a comprehensive analysis of the global Vascular Closure Device​ landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Closure Device​ portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Closure Device​ market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Closure Device​ and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Closure Device​.

This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Closure Device​ market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
The Collagen Plug-Based
The Suture Based
The Nitinol Clip-Based

Segmentation by Application:
Angiography
Interventional Surgeries

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Teleflex Incorporated
Abbott Laboratories
Boston Scientific Corporation
BD
Medtronic
Cook
Vivasure Medical
Cordis (Cardinal Health)
Transluminal Technologies
InSeal Medical
Medeon Biodesign
Vivasure Medical Limited
Haemonetics
Terumo Corporation
Vasorum

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vascular Closure Device​ market?

What factors are driving Vascular Closure Device​ market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vascular Closure Device​ market opportunities vary by end market size?

How does Vascular Closure Device​ break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.